跳至主要内容
临床试验/JPRN-UMIN000040586
JPRN-UMIN000040586已完成未知

Prospective observational study investigating the impact of treatment sequence using regorafenib and FTD/TPI for metastatic colorectal cancer on overall survival - OSERO study

Kyushu Study group of Clinical Cancer0 个研究点目标入组 501 人开始时间: 2020年7月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
501

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Prior treatment with regorafenib or FTD/TPI 2)Patients with active multiple cancers 3)Patients who have symptomatic brain metastases. 4)Patients with diabetes mellitus, hyper tension, angina unstable, or symptomatic congestive heart failure (NYHA III/IV) that cannot be controlled adequately with medication. 5)Patients whom a lead investigator or primary physician deems are not appropriate for this study.

研究者

发起方
Kyushu Study group of Clinical Cancer

相似试验